Cargando…
K-Ras Peptide Mimotope Induces Antigen Specific Th1 and B-Cell Immune Responses against G12A-Mutated K-Ras Antigen in Balb/c Mice
KRAS G12A somatic point mutation in adenocarcinomas is categorized clinically as ineligibility criteria for anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapies. In this study, a modified G12A-K-ras epitope (139A) with sequence-specific modifications to improve immunogenicity w...
Autores principales: | Siak, Pui Yan, Wong, Kuan Yee, Song, Adelene Ai-Lian, Rahim, Raha Abdul, In, Lionel Lian Aun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996567/ https://www.ncbi.nlm.nih.gov/pubmed/33652552 http://dx.doi.org/10.3390/vaccines9030195 |
Ejemplares similares
-
In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens
por: Ng, Allan Wee Ren, et al.
Publicado: (2018) -
Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer
por: Alias, Nur Aqlili Riana, et al.
Publicado: (2023) -
Optimization of Signal Peptide via Site-Directed Mutagenesis for Enhanced Secretion of Heterologous Proteins in Lactococcus lactis
por: Alias, Nur Aqlili Riana, et al.
Publicado: (2022) -
Killer K-Ras
por: Powell, Kendall
Publicado: (2006) -
K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)